WAM
SPPI

Wolverine Asset Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Wolverine Asset Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-109
Closed – – 1753
2019
Q4 		$0 Hold
109
– – ﹤0.01% 1572
2019
Q3 		$0 Hold
109
– – ﹤0.01% 1681
2019
Q2 		$0 Hold
109
– – ﹤0.01% 1636
2019
Q1 		$1K Hold
109
– – ﹤0.01% 1326
2018
Q4 		$0 Buy
+109
New +$1.39K ﹤0.01% 1803
2013
Q4 		– Sell
-11,898
Closed -$106K – 2985
2013
Q3 		$99K Hold
11,898
– – ﹤0.01% 1459
2013
Q2 		$88K Buy
+11,898
New +$91.3K ﹤0.01% 1478

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wolverine Asset Management's SPPI Position: Q1 2020 in Review

Wolverine Asset Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2020, closing a stake of 109 shares.

Wolverine Asset Management first reported a position in SPPI in Q2 2013 and held it in 7 quarters. The position peaked at $99K in Q3 2013. 156 funds tracked by Wall St. Rank hold SPPI as of Q1 2020.

  • Wolverine Asset Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2020 after selling out during the quarter.
  • Wolverine Asset Management sold 109 Spectrum Pharmaceuticals Inc shares in Q1 2020.
  • Wolverine Asset Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 7 quarters.
  • Wolverine Asset Management's Spectrum Pharmaceuticals Inc position peaked at $99K in Q3 2013.
  • 156 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2020.

Based on Wolverine Asset Management's 13F filing for Q1 2020, filed 13 May 2020.